Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fushen is a specialized medicinal part of the fungus *Poria cocos* (Schw.) Wolf, specifically referring to the sclerotium that has grown around and contains a portion of the host pine root (*Pinus* spp.). It is distinguished in Traditional Chinese Medicine (TCM) from other parts of the *Poria* fungus (such as Fuling or Poria Cutis) by its specific mind-tranquilizing and sedative properties. Bioactive components include triterpenoids (such as pachymic acid and dehydroeburicoic acid) and polysaccharides. Research indicates that Fushen exerts therapeutic effects by modulating the 5-hydroxytryptamine (5-HT) and GABAergic systems for insomnia, and by inhibiting inflammatory and oxidative stress pathways such as TLR4/NF-κB, p38MAPK, and Nrf2/HO-1 in the context of chronic renal failure and peritoneal dialysis-related peritonitis. It is also noted for its ability to regulate gut microbiota and protect the intestinal barrier.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fushen.